ATE78692T1 - Antivirale therapie gegen hepatitis b mit 2',3'- didesoxynucleosiden. - Google Patents

Antivirale therapie gegen hepatitis b mit 2',3'- didesoxynucleosiden.

Info

Publication number
ATE78692T1
ATE78692T1 AT88307307T AT88307307T ATE78692T1 AT E78692 T1 ATE78692 T1 AT E78692T1 AT 88307307 T AT88307307 T AT 88307307T AT 88307307 T AT88307307 T AT 88307307T AT E78692 T1 ATE78692 T1 AT E78692T1
Authority
AT
Austria
Prior art keywords
hepadnavirus
virus
dideoxynucleoside
purine
duck hepatitis
Prior art date
Application number
AT88307307T
Other languages
English (en)
Inventor
David L J Tyrrell
Morris J Robins
Satoru Suzuki
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Application granted granted Critical
Publication of ATE78692T1 publication Critical patent/ATE78692T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT88307307T 1987-08-07 1988-08-08 Antivirale therapie gegen hepatitis b mit 2',3'- didesoxynucleosiden. ATE78692T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17819687A 1987-08-07 1987-08-07
EP88307307A EP0302760B1 (de) 1987-08-07 1988-08-08 Antivirale Therapie gegen Hepatitis B mit 2',3'-Didesoxynucleosiden

Publications (1)

Publication Number Publication Date
ATE78692T1 true ATE78692T1 (de) 1992-08-15

Family

ID=22651606

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88307307T ATE78692T1 (de) 1987-08-07 1988-08-08 Antivirale therapie gegen hepatitis b mit 2',3'- didesoxynucleosiden.

Country Status (9)

Country Link
EP (1) EP0302760B1 (de)
JP (1) JP2899292B2 (de)
KR (1) KR940010441B1 (de)
AT (1) ATE78692T1 (de)
AU (1) AU623341B2 (de)
CA (1) CA1327000C (de)
DE (1) DE3873207T2 (de)
ES (1) ES2043831T3 (de)
HK (1) HK1000112A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5013829A (en) * 1989-04-26 1991-05-07 University Of Iowa Research Foundation Stable congener of 2',3'-dideoxyadenosine
WO1990014079A1 (en) * 1989-05-15 1990-11-29 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method of treatment of hepatitis
CA2054771A1 (en) * 1989-05-15 1990-11-16 Hiroaki Mitsuya Method of treatment of hepatitis
US5026687A (en) * 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
IL100502A (en) * 1991-01-03 1995-12-08 Iaf Biochem Int PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (-
DE4110977A1 (de) * 1991-04-05 1992-10-08 Bayer Ag Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB9110874D0 (en) * 1991-05-20 1991-07-10 Iaf Biochem Int Medicaments
DE4207363A1 (de) * 1992-03-04 1993-09-09 Max Delbrueck Centrum Antivirale nucleosidanaloga, ihre herstellung und ihre pharmazeutische verwendung
GB9226927D0 (en) * 1992-12-24 1993-02-17 Iaf Biochem Int Dideoxy nucleoside analogues
CA2637774C (en) * 1993-09-10 2011-07-19 Emory University Nucleosides with anti-hepatitis b virus activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196607B (en) * 1985-05-15 1988-12-28 Wellcome Found Process for producing dideoxy-nucleosides and pharmaceutics comprising such compounds

Also Published As

Publication number Publication date
CA1327000C (en) 1994-02-15
JP2899292B2 (ja) 1999-06-02
KR890003384A (ko) 1989-04-14
EP0302760A2 (de) 1989-02-08
DE3873207D1 (en) 1992-09-03
EP0302760A3 (en) 1989-08-09
ES2043831T3 (es) 1994-01-01
JPH0285215A (ja) 1990-03-26
DE3873207T2 (de) 1993-01-07
AU623341B2 (en) 1992-05-14
HK1000112A1 (en) 1997-12-05
AU2050288A (en) 1989-02-09
KR940010441B1 (ko) 1994-10-22
EP0302760B1 (de) 1992-07-29

Similar Documents

Publication Publication Date Title
ATE78692T1 (de) Antivirale therapie gegen hepatitis b mit 2',3'- didesoxynucleosiden.
KR900701817A (ko) 뉴클레오사이드 유도체와 그의 제조방법
DE69929060D1 (de) Beta-l-2'-deoxynukleoside für die behandlung von hepatitis b virus
ES8802616A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene 3'-azido-3'-desoxitimidina o uno de sus derivados farmaceuticamente aceptables.
PA8483101A1 (es) Compuestos quimicos
MD950086A (ro) Utilizare a analogilor nucleozidici ai 1,3-oxatiolanei in tratamentul hepatitei B Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis B
FI962986A0 (fi) L-nukleosidejä hepatiitti-B-viruksen ja Epstein-Barr-viruksen hoitamiseksi
ES2115918T3 (es) Nucleosidos de beta-d-dioxolano de pureza enantiomera y de actividad dirigida selectivamente contra el virus de la hepatitis b.
ATE135365T1 (de) Antivirale verbindungen
KR930019213A (ko) 간염치료에 유용한 1,3-옥사티올란류
DK148279C (da) Analogifremgangsmaade til fremstilling af 9-substituerede guaninderivater eller fysiologisk acceptable salte eller optiske isomerer deraf
SE8602981D0 (sv) Novel medicinal use
JPH05509307A (ja) プリンの抗ウイルス性ホスホノ―アルケン誘導体
KR910000734A (ko) 네플라노신 유도체
KR950701638A (ko) 푸린 동족체의 항비루스성 포스폰산 유도체(Antiviral phosphonic acid derivatives of purine analogues)
DK462688A (da) Anvendelse af nukleosider til fremstilling af laegemiddel til behandling af sygdomme foraarsaget af retrovirus eller hepatitis b virus
DE69019404D1 (de) Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen.
KR900018095A (ko) 신규 화합물들
SE7702231L (sv) Sett att framstella en substituerad purin
EP0286825A3 (de) Verwendung von 3'-fluro-3'-deoxythymidine zur Herstellung von medicamenten zur Behandlung von Viruskrankheiten
KR960704464A (ko) 포유동물 세포에서의 뉴클레오사이드와 뉴클레오베이스 수송억제 방법 및 바이러스 복제억제 방법(method for inhibiting nucleoside and nucleoside transport and virus replication in mammalian cells)
EP0274901A3 (de) Streptovaricin C-Derivate als Mittel gegen HTLV-I-Viren
KR950703976A (ko) 아시클로비르 유사 화합물과 2′-비닐 치환 뉴클레오시드 유사체를 함유하는 바이러스 감염 치료용 조성물(Compositions Containing Acyclovir-Like Compounds and 2′-Vinyl substituted Nucleoside Analogs for the Treatment of Viral Infections)
Dianzani et al. Antiviral Drugs
TH9840A (th) สารประกอบต้านไวรัส

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee